Dayna Goltz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dayna Goltz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Adam Golden
School of Global Health Management and Informatics, University of Central Florida, Orlando, FL, USA
1 shared publication- Adewale Segun James
Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, USA
1 shared publication Ambuj Kumar
Research Methodology and Biostatistics, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA
1 shared publicationAmoy Fraser
School of Global Health Management and Informatics, University of Central Florida, Orlando, FL, USA
1 shared publicationAndrea Y. Arikawa
Department of Nutrition and Dietetics, University of North Florida, Jacksonville, FL, USA
1 shared publicationCorinne Labyak
Department of Nutrition and Dietetics, University of North Florida, Jacksonville, FL, USA
1 shared publication
Latest Publications
- Open Access
- 16 December 2024
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2431648
Abnormalities in gut virome signatures linked with cognitive impairment in older adults
Multiple emerging lines of evidence indicate that the microbiome contributes to aging and cognitive health. However, the roles of distinct microbial components, such as viruses (virome) and their interactions with bacteria (bacteriome), as well as their metabolic pathways (metabolome) in relation to aging and cognitive function, remain poorly understood. Here, we present proof-of-concept results from a pilot study using datasets (n = 176) from the Microbiome in Aging Gut and Brain (MiaGB) consortium, demonstrating that the human virome signature significantly differs across the aging continuum (60s vs. 70s vs. 80+ years of age) in older adults. We observed that the predominant virome signature was enriched with bacteriophages, which change considerably with aging continuum. Analyses of interactions between phages and the host bacteriome suggest that lytic or temperate relationships change distinctly across the aging continuum, as well as cognitive impairment. Interestingly, the phage-bacteriome-metabolome interactions develop unique patterns that are distinctly linked to aging and cognitive dysfunction in older adults. The phage-bacteriome interactions affect bacterial metabolic pathways, potentially impacting older adults' health, including the risk of cognitive decline and dementia. Further comprehension of these studies could provide opportunities to target the microbiome by developing phage therapies to improve aging and brain health in older adults.
- 16 December 2024
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2431648
Open AccessAbnormalities in gut virome signatures linked with cognitive impairment in older adults
Multiple emerging lines of evidence indicate that the microbiome contributes to aging and cognitive health. However, the roles of distinct microbial components, such as viruses (virome) and their interactions with bacteria (bacteriome), as well as their metabolic pathways (metabolome) in relation to aging and cognitive function, remain poorly understood. Here, we present proof-of-concept results from a pilot study using datasets (n = 176) from the Microbiome in Aging Gut and Brain (MiaGB) consortium, demonstrating that the human virome signature significantly differs across the aging continuum (60s vs. 70s vs. 80+ years of age) in older adults. We observed that the predominant virome signature was enriched with bacteriophages, which change considerably with aging continuum. Analyses of interactions between phages and the host bacteriome suggest that lytic or temperate relationships change distinctly across the aging continuum, as well as cognitive impairment. Interestingly, the phage-bacteriome-metabolome interactions develop unique patterns that are distinctly linked to aging and cognitive dysfunction in older adults. The phage-bacteriome interactions affect bacterial metabolic pathways, potentially impacting older adults' health, including the risk of cognitive decline and dementia. Further comprehension of these studies could provide opportunities to target the microbiome by developing phage therapies to improve aging and brain health in older adults.